AI to Detect Lung Cancer Early in Telangana

AstraZeneca Pharma India, in partnership with the Telangana government, is set to introduce AI-powered lung cancer screening at 20 public health facilities. This initiative aims to enhance the early detection of lung cancer across both urban and rural areas within Telangana. The program will employ an Indian startup's AI solution for chest X-rays, assisting clinicians in identifying potential precursors to lung cancer and other lung conditions. Patients identified as high-risk will be directed to appropriate diagnostic and follow-up services. This collaboration addresses the increasing burden of lung cancer in India, where a significant percentage of diagnoses occur at advanced stages, leading to substantial mortality. Telangana is also experiencing a growing cancer prevalence. Health officials emphasize that integrating technology into public healthcare is crucial for tackling late diagnoses. AstraZeneca's country president highlighted that early detection is key to improving patient outcomes, and the rollout includes training for healthcare professionals and infrastructure support for sustained implementation.